Literature DB >> 8621473

A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis.

J J Hunter1, T G Parslow.   

Abstract

Bcl-2 and Bax are members of a family of cytoplasmic proteins that regulate apoptosis. The two proteins have highly similar amino acid sequences but are functionally opposed: Bcl-2 acts to inhibit apoptosis, whereas Bax counteracts this effect. The antagonism appears to depend upon dimerization between Bcl-2 and Bax, but its mechanism is otherwise unknown. Here we report that overexpressing Bax induces apoptosis in a mammalian fibroblast cell line, and we identify a novel, short "suicide domain" in Bax that is required for this effect. Inserting this domain in place of the corresponding, divergent sequence in Bcl-2 converts Bcl-2 from an inhibitor into an activator of cell death. These findings imply that a specific region in Bax confers an active propensity for apoptosis in mammalian cells and support the view that Bcl-2 may block death primarily by suppressing Bax activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621473     DOI: 10.1074/jbc.271.15.8521

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria.

Authors:  B Antonsson; S Montessuit; S Lauper; R Eskes; J C Martinou
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

2.  Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS.

Authors:  M Di Renzo; D Serrano; Z Zhou; I George; K Becker; C Cunningham-Rundles
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

3.  NMR determination that an extended BH3 motif of pro-apoptotic BID is specifically bound to BCL-XL.

Authors:  Hong Ji; Alex Shekhtman; Ranajeet Ghose; James M McDonnell; David Cowburn
Journal:  Magn Reson Chem       Date:  2006-07       Impact factor: 2.447

4.  The structure of the C-terminal domain of the pro-apoptotic protein Bak and its interaction with model membranes.

Authors:  María del Mar Martínez-Senac; Senena Corbalán-García; Juan C Gómez-Fernández
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

5.  Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing.

Authors:  K Wang; A Gross; G Waksman; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

6.  Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2.

Authors:  P H Schlesinger; A Gross; X M Yin; K Yamamoto; M Saito; G Waksman; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

7.  Modulation of cell death by Bcl-XL through caspase interaction.

Authors:  R J Clem; E H Cheng; C L Karp; D G Kirsch; K Ueno; A Takahashi; M B Kastan; D E Griffin; W C Earnshaw; M A Veliuona; J M Hardwick
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

8.  Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL.

Authors:  A Kelekar; B S Chang; J E Harlan; S W Fesik; C B Thompson
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

9.  Gentamicin causes apoptosis at low concentrations in renal LLC-PK1 cells subjected to electroporation.

Authors:  Hélène Servais; Yves Jossin; Françoise Van Bambeke; Paul M Tulkens; Marie-Paule Mingeot-Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

10.  Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways.

Authors:  Bruno Antonsson
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.